What you should know:
1. Curiteva will use $2.2 million to pay off promissory notes and liquidation preferences. The company did not elaborate on what it would use the remaining funds for.
2. Curiteva developed the Sage cervical interbody fusion system and the Aptitude cervical plates.
3. The company is attempting to raise $20 million through the offering.
More articles on surface technology:
2 hospitals losing neurosurgery residency programs
Rothman, Carrum Health partner to expand healthcare benefits into tri-state area
Nexxt Spine to expand headquarters — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
